The advertisement promotes AUSTEDO XR and AUSTEDO, highlighting their exclusivity on specific insurance formularies while providing important safety information regarding the risks of depression and suicidality associated with their use in patients with Huntington's disease.
Creative Information
| CID: | 2a579141-68de-424c-8db6-6f5d34e68459 |
| CRID: | 2_206_473653 |
| Domain: | tevapharm.com |
| Seat: | BSW |
| Size: | 728x90 |
| Bid: | $14.26 |
| Timestamp: | 12/18/2025, 8:55:45 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/18/2025, 8:56:09 PM | 6.08s | |
| adomain_analysis | success | 12/18/2025, 8:55:50 PM | 3.98s | |
| adomain_capture | success | 12/18/2025, 8:55:46 PM | 0.20s | |
| ad_render | success | 12/18/2025, 8:56:03 PM | 17.43s | |
| brand_mapping | success | 12/18/2025, 8:55:45 PM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: Teva
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1334.75 KB | ||||||||||||||||||||||
| Render Time: | 8.55 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 1354.01 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Raw Ad Markup
<script src="https://tagan.adlightning.com/iponweb/blacklist_script.js" type="text/javascript"></script>
<script src="https://tagan.adlightning.com/iponweb/blocking_script.js" type="text/javascript"></script>
<script type="text/javascript">
function createTagDetails(){
var tagDetails = {};
tagDetails.w = '728';
tagDetails.h = '90';
tagDetails.adServerDetails = {advertiserId: 'kargo', campaignId: '206', creativeId: '206_473653', lineitemId: '0', adServer: 'dfp'};
tagDetails.au = '0';
tagDetails.markupInDom = true;
tagDetails.utilizeParentInfo = true;
var timeBase36 = Date.now().toString(36);
var random = Math.random().toString(36).substr(2).split('')
.map(function (c) {
return (Math.random() < 0.5 ? c.toUpperCase() : c); }) .join('');
tagDetails.currentTagId="adltag_" + timeBase36 + "_" + random;
return tagDetails;
}
var random = "" + Math.round(Math.random() * 1e8);
var clientId = "iponweb";
var site_id = random + "_" + clientId;
window[site_id]={};
window[site_id].tagDetails=createTagDetails();
!function(){"use strict";"blocker"in window||(window.blocker=function(e,n,o,i,t){if((t=t||{}).bw){if(Math.random()<.1){var r="undefined"!=typeof btoa?btoa:String,a="https://"+clientId+"-tagan.adlightning.com",d={siteId:clientId,url:window.top.location.href,tagDetails:window[e],errorData:null,errorMethod:"missing_blocker"},c=encodeURIComponent(JSON.stringify(d)).replace(/%([0-9A-F]{2})/g,function(e,n){return String.fromCharCode("0x"+n)});!function(e){var n=window.Request,o=n&&n.prototype||{};if(navigator&&navigator.sendBeacon)navigator.sendBeacon(e);else if(window.fetch){var i={method:"GET"};"keepalive"in o&&(i.keepalive=!0),window.fetch(e,i)}else{var t=new Image(1,1);"loading"in t&&(t.loading="eager"),t.src=e}}(a+"/error?d="+encodeURIComponent(r(c)))}document.write(n)}})}();
blocker(site_id, "<!--ADL_WRAPPED-->", false, window, {fr: true});
</script>
<ins class='dcmads' style='display:inline-block;width:728px;height:90px' data-dcm-placement='N733.2055741ADTHEORANT/B32697646.414539228' data-dcm-rendering-mode='script' data-dcm-https-only data-dcm-keywords='e8046b77-ca7a-11f0-8009-42010ab200db' data-dcm-click-tracker='https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D473653%3BsId%3D754058%3BlId%3D91645%3BcId%3D17884%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3De8046b77-ca7a-11f0-8009-42010ab200db%3BadThdId%3Ddad023f5ab0fe924fdf4eac7d5954f0a%3BengineId%3D2530057042633229249%3BdIp%3DOC4xNC41OC4yMTk%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D90656%3BinventoryId%3D271029%3BrtdmIndicator%3D1%3Btimestamp%3D1764128967%3Blat%3DMjYuNTE%3Blong%3DLTgxLjc0%3Bdma%3DNTcx%3BstateCode%3D%3Bzip%3DMzM5Mjg%3Bbsc%3D${CLICK_URL_ENC}%3Bredir%3D' data-dcm-resettable-device-id='' data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=${GDPR}' data-dcm-gdpr-consent='gdpr_consent=${GDPR_CONSENT_755}' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-app-id=''> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins><img src='https://rtb.adentifi.com/Imps?impId=1;adId=e8046b77-ca7a-11f0-8009-42010ab200db;lId=91645;sId=754058;cId=17884;crId=473653;adThdId=dad023f5ab0fe924fdf4eac7d5954f0a;adExchange=BidSwitch;engineId=2530057042633229249;dealId=0;geoId=90656;inventoryId=271029;rtdmIndicator=1;timestamp=1764128967;property=nypost.com;dIp=OC4xNC41OC4yMTk;dIpv6=;adThdIdCode=WEB_MD5_V4;thirdPartyIdType=1;npiKey=-4856998056480419404;hhId=253121411;cuid=cuid_36216071-8729-11ee-a1b7-125edd13ad3d' style='display:none; width:0px; height:0px;' /><script src="https://tags.bkrtx.com/js/bk-coretag.js"></script><script>bk_addPageCtx("id","cuid_36216071-8729-11ee-a1b7-125edd13ad3d");bk_allow_multiple_calls = true;bk_use_multiple_iframes = true;bk_send_statid_payload = true;bk_use_image = true;bk_callback = true;bk_doJSTag(18840, 4);</script><span id="te-clearads-js-adtheorent01cont473653"><script type="text/javascript" src="//choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=17884&c=adtheorent01cont473653&w=728&h=90&js=pmw0&plc=tr&uid=dad023f5ab0fe924fdf4eac7d5954f0a"></script></span><img src="https://us-east-sync.bidswitch.net/sync?ssp=kargo&dsp_id=206&imp=1" alt=" " style="display:none"/>Creatives
